0      0

ACR 2015 The Crossroads of Radiology


Molecular Imaging in Dementia: Clinical Research to Clinical Translation


May 18, 2015 10:00am ‐ May 18, 2015 12:00pm

Description

This session will provide attendees with information about new research in radiopharmaceuticals to evaluate dementia and with information about the use of molecular brain imaging in clinical trials of anti-Alzheimer's therapies. Attendees will develop a better understanding of the regulatory processes leading to translation of amyloid-binding radiopharmaceuticals into the clinic. This information will help attendees make their facilities referral sites for amyloid imaging in clinical trials. 

Subspecialties: MI, NU
Modalities: NM

Speaker(s):

Disclosures

  • Satoshi Minoshima, MD, PhD : Consultant: Hamamatsu Photonics; Royalty Income: GE Healthcare; Research Grants: Hitachi Medical Corp, Phillips Healthcare, Nihon Medi Physics, Seattle Genetics, Astellas Pharma
  • Kirk Frey, MD, PHD : Consultant: MIM Software Inc, Bayer Healthcare, Avid Radiophamraceuticals; Research Grants: GE Healthcare 
  • John Seibyl, MD : Ownership/Partnership: Molecular Neuroimaging, LLC -equity

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content